Hearing
Flu Vaccine: Protecting High-Risk Individuals and Strengthening the Market
Subcommittee on Health
November 18, 2004
2123 Rayburn House Office Building
09:30 AM
Hearing Webcast: Archived
Connect to the archive of this hearing webcast.
Committee web casts
require the free Real Player.
Witness
List & Prepared Testimony
|
|
Mr. Lester M. Crawford D.V.M., Ph.D.
Acting Commissioner
Food and Drug Administration
5600 Fishers Lane
Rockville, MD, 20857 | Dr. Anthony S. Fauci M.D.
Director, National Institute of Allergy and Infectious Diseases
National Institutes of Health
6610 Rockledge Drive, MSC 6612
Bethesda, MD, 20892-6612 | Dr. Julie Louise Gerberding MD, MPH
Director
Centers for Disease Control and Prevention
1600 Clifton Road
Atlanta, GA, 30333 |
|
|
Ms. Janet Olszewski
Director
Michigan Dept of Community Health
Lewis Cass Building
320 South Walnut
Lansing, MI, 48913 | Ms. Janet Heinrich
Director, Healthcare/Public Health Issues
US Government Accountability Office
441 G St., NW
Washington, DC, 20548 | Mr. Alan Rosenbloom
President and CEO
Pennsylvania Health Care Association/ Center for Assisted Living Management
315 N 2nd St
Harrisburg, PA, 17101 | Mr. Peter Paradiso Ph.D.
Vice President, New Business Development
Wyeth
500 Arcola Road
Collegeville, PA, 19426 | Mr. Mark Mlotek
Executive Vice President
Henry Schein, Inc.
135 Duryea Road
Melville, NY, 11747 | Ms. Kathleen Coelingh
Senior Director for Regulatory and Scientific Affairs
MedImmune, Inc.
One MedImmune Way
Gaithersburg, MD, 20878 |
Hearing
Transcript: Not Available
The transcript of this hearing should be available within 60-90 days of the conclusion of the hearing.
Click here for the latest list of available hearing transcripts..
Available Member Statements
There are no prepared Member Statements currently available.
|
